Infinity Pharmaceuticals Stock Analysis
Technical stock analysis for Tue 11'th Dec 2018
Infinity Pharmaceuticals gained 0.79% in the last trading day, rising from $1.26 to $1.27 The price has fallen in 5 of the last 10 days and is down by -7.3% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 143 991 more shares were traded than the day before. In total, 268 859 shares bought and sold for approximately $341 451.00.
Infinity Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.10% during the next 3 months and, with 90% probability hold a price between $0.54 and $1.21 at the end of this period.
A buy signal was issued from a pivot bottom point on Tuesday December 04, 2018, which indicates further gains until a new top pivot has been found. Infinity Pharmaceuticals has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Infinity Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.27 and $1.74. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 38 and the stock is currently not being overbought or oversold
Support & Resistance
Infinity Pharmaceuticals finds support from accumulated volume at $1.26.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 9.02%. For the last week, the stock has had a daily average volatility of 8.04%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Infinity Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|INFI $1.27 $0.01(0.79%)|
INFI is up $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for INFI based on the 1-3 month system that more than doubles the S&P 500.
Click here – the INFI analysis is free »